weight regain tirzepatide JAMA on X: "In participants with obesity/overweight, withdrawing led to substantial of lost weight, whereas continued treatment maintained and augmented initial reduction. https://t.co/3GCKBNFLgo https://t.co/3lULIpReRI" / X People Who Stopped Taking the

This internal study will provide valuable insights and guide future recommendations for patients transitioning off GLP-1 medications

GLP-1 Therapy Semaglutide and Tirzepatide are GLP-1 receptor agonists that reduce insulin resistance, regulate blood sugar, suppress appetite, and promote sustainable fat loss targeting the metabolic engine driving most PMOS symptoms

10.1038/onc.2017.146 Oncogene 10 ChenY.ZuliyaerT.LiuB.GuoS.YangD.GaoF.et al (2022)

We talk about that

Your individual health objectives, current B12 levels, and complete medical history will always be considered to ensure your plan is both safe and effective